Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Xenetic Biosciences (XBIO) Assets Average (2023 - 2025)

Xenetic Biosciences' Assets Average history spans 6 years, with the latest figure at $6.7 million for Q4 2025.

  • For Q4 2025, Assets Average fell 10.14% year-over-year to $6.7 million; the TTM value through Dec 2025 reached $6.7 million, down 10.14%, while the annual FY2025 figure was $7.6 million, 12.8% down from the prior year.
  • Assets Average reached $6.7 million in Q4 2025 per XBIO's latest filing, up from $5.2 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $16.5 million in Q1 2023 to a low of $5.2 million in Q3 2025.
  • Average Assets Average over 3 years is $9.4 million, with a median of $8.9 million recorded in 2024.
  • The largest YoY upside for Assets Average was 10.14% in 2025 against a maximum downside of 39.52% in 2025.
  • A 3-year view of Assets Average shows it stood at $11.3 million in 2023, then plummeted by 33.76% to $7.5 million in 2024, then decreased by 10.14% to $6.7 million in 2025.
  • Per Business Quant, the three most recent readings for XBIO's Assets Average are $6.7 million (Q4 2025), $5.2 million (Q3 2025), and $5.6 million (Q2 2025).